Article
Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies.
mBio - 14 Feb 2024
Contreras Maya, Stuart Jackson B, Levoir Lisa M, Belmont Laura, Goo Leslie
Abstract excerpt
Antibodies targeting an envelope dimer epitope (EDE) cross-neutralize Zika virus (ZIKV) and dengue virus (DENV) and have thus inspired an epitope-focused vaccine design. There are two EDE antibody subclasses (EDE1, EDE2) distinguished by their dependence on viral envelope protein N-linked glycosylation at position N153 (DENV) or N154 (ZIKV) for binding. Here, we determined how envelope glycosylation site...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
